P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET). (23rd June 2022)

• Record Type: Journal Article
• Authors: Palandri, F.; Ross, D. M.; Cochrane, T.; Tate, C.; Lane, S. W.; Larsen, S. R.; Gerds, A. T.; Halpern, A. B.; Shortt, J.; Rossetti, J. M.; Pettit, K. M.; Liang, J.; Mead, A.; Marchetti, M.; Vannucchi, A.; Wilson, A.; Göthert, J. R.; Hanna, M.; Jones, A.; Peppe, J.; Natsoulis, G.; McClure, T.; Hong, W.-J.; Stevenson, W. S.; Harrison, C. N.; Talpaz, M.; Vianelli, N.; Rienhoff, H. Y.
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 923
• Page End: 924
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000847000.38667.91
• Languages: English
• ISSNs: 2572-9241